Member Info for researcher1

the RNS is far more interesting - the ducks are definitely in row....

Berenberg are Angle's new NOMAD, so bound to be positive, but I'm actually disappointed at that valuation - any one of the multiple strands (MBC, Ovarian, prostate, clinical services - the list goes on..) is worth that alone, and FDA approval will take the SP beyond there anyway - of course they will update following that, but show some confidence guys...!

a sign of the bottom, or same old same old?

agree with the 'start saving lives' sentiment Hawk - about time the FDA recognised the collateral damage of their delay.
don't agree with your "another positive piece of news" - today's is exceptional!

not sure where you buy your elephants Bojo, but mine weights 12,000 lbs....

good to see you over here lately sicilian, your insights over on advfn have been exceptional. In agree with you this morning that the RNS allays fears that the Ovarian delay was due to less than impressive results - personally I feel relief. AN's comments regarding FDA are also particularly upbeat for someone usually extremely cautious.

managed to pick up an extra £20K at just under 110 this morning - thank you 'supply chain issue'.

what happened to the elephant, mia?

thanks Bojo, yes still have loads of SCLP, all bought around 5p I'm happy to report!

good, leave here and invest in those dividend stocks oilhead (name says it all?). If you read the RNS it indicates constructive liaison with FDA, so your "another form of consultation" is ongoing....
Personally I'm delighted to be able to buy more at this morning's price.

maybe too much of a conspiracy theory - I sold a batch of my 37p shares to pay for a barn conversion (though I have x4 as many remaining) at these levels, two years on from the Jupiter fiasco, folk are allowed to access profits etc....

you are probably right, but the buying/selling patterns have shifted significantly - makes me suspect something brewing....

is it just me, or are things about to get interesting this afternoon?

excellent spot Bermuda, thanks. Crikey, where will the SP be in a few months!

it's a game of chicken regarding SO's intentions isn't it? - as soon as it is known he has stopped selling (for one reason or another) there will be the most almighty scramble up to 90p minimum (and beyond eventually, of course). I'm buying down here, but not huge chunks just yet - happier to buy big on the way up, as previously. When it hits 90p I should be able to retire... :-)

these complementary uses are building into a revenue channel of immense potential....

FDA Maryland on EST opens 2.00 GMT - Wall Street at 2.30 GMT, if you see what I mean...
but who knows - SK on Advfn did some research on this and determined that a Friday at 2pm GMT was most likely....

agreed bermuda - though they may still decide a later RNS so that the US is awake?

hi Jakey - I did email them on Monday night, so am hoping for a reply perhaps tomorrow - will keep you posted...

ha ha Jake, that's paranoid indeed! Perhaps consider the exhaustive breadth and depth of Angle's peer reviews, not to mention the fact that Angle is already working on two contracts in the USA as well as the UK. One salient point arising from your fear-mongering is that the FDA denied Angle's first broad spectrum approach and asked the company to resubmit for specific, already identified (prior to taking blood) cancer types. Spot the difference? Chalk and cheese.